About us

Founded in 1927, Nordmark is a specialist for the development, manufacturing and commercialization of active pharmaceutical ingredients (APIs) and drug products.

Headquartered in Uetersen near Hamburg, and family owned again after a management buyout from the BASF group in 2001, Nordmark today employs more than 500 employees and generated revenues of around EUR 90 million in 2018.

With 90 years of excellence and commercial success, Nordmark is the ideal partner to bring your ideas to market.

Nordmark Biotech, the biotechnological division of Nordmark, is offering an all-in-one solution for Mammalian Cell Culture, Microbial Fermentation and Microbiome products covering the entire value chain from process development, analytics, production of API and finished drug product up to regulatory affairs and marketing approval.

Our worldwide customers benefit from this integrated approach, which is based on solid project management, long-standing GMP experience and recurrent EMA and FDA approvals.

Products and services

Nordmark Biotech is able to cover the entire value chain from process development to marketed drug products. We manufacture APIs and finished drug products for recognized pharma companies as well as for our own brands according to cGMP.

Our value addes services include pharmaceutical and analytical method development, stability testing and regulatory support during approval processes (worldwide).

At Nordmark Biotech we account for each customer’s individual need for customized project support – from the first idea to supplying the finished drug product. In close cooperation with our customers, we define exact project goals, clear structures and responsibilities. Our project manager is your primary contact and is responsible for steering the entire process and driving the project to success.

As a family owned business we are used to work with maximum care and attention and lean decision making processes. We are committed to your success – regardless of project size.

Collagenase

Collagenase is an enzyme preparation made of Clostridium histolyticum. At Nordmark, collagenase products are manufactured for two different applications: as active ingredients for wound treatment ointments  (Collagenase N Powder) and as biochemicals  (Collagenase NB) for use in analytical and medical tissue engineering laboratories. As the World’s largest collagenase manufacturer, Nordmark operates a production plant specifically built for collagenase manufacturing purposes.

Further reading

Address
Nordmark Biotech
Pinnauallee 4
25436 Uetersen
Germany

Phone: +49 4122 7120
Internet: www.nordmark-biotech.de
E-mail: Send message

Contact person

Dr. Jan Heyland
Head of Biotech Development
E-mail: Send message

Representative
BIBITEC GmbH
Meisenstr. 96
33607 Bielefeld
Germany

Internet: www.bibitec.de
E-mail: Send message

Click here if you notice an image that violates copyright or privacy rights.

Get in contact
OK

We use cookies and the web analysis tool Matomo in order to optimally design and continuously improve our website for you. By continuing to use our website, you agree to this. Further information and an objection possibility can be found here: Data protection